Wolf Myles 4
4 · Akebia Therapeutics, Inc. · Filed Apr 7, 2020
Insider Transaction Report
Form 4
Wolf Myles
Director
Transactions
- Award
Stock Option (Right to buy)
2020-04-06+80,200→ 80,200 totalExercise: $7.09Exp: 2030-04-06→ Common Stock (80,200 underlying)
Footnotes (1)
- [F1]The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter.